CSL

U.S. gov awards CSL Biotherapies contract for influenza pandemic preparedness

Friday, September 14, 2012 12:07 PM

CSL Biotherapies, a King of Prussia, Penn.-based subsidiary of CSL Limited, a manufacturers of influenza vaccines, has been awarded a contract by the U.S. Department of Health and Human Services to supply pre-pandemic and pandemic vaccine antigens and related services to the U.S. national stockpile.

More... »


CSL, Selexis ink commercial license agreement

Wednesday, July 27, 2011 01:12 PM

Australia-based CSL has entered into a commercial license agreement with Selexis, headquartered in Switzerland, for the pre-clinical development of a therapeutic antibody anticipated to enter phase I clinical trials in 2012. This commercial license agreement provides CSL with the rights to use a cell line, generated using the Selexis SUREtechnology Platform, for the cGMP production of an undisclosed antibody.

More... »


Aires Pharmaceuticals appoints Edwin L. Parsley as CMO

Wednesday, May 4, 2011 01:05 PM

Aires Pharmaceuticals has hired Ed Parsley, D.O., as chief medical officer.  Parsley will be responsible for all clinical development activities for Aironite, the company's lead product for treatment of pulmonary arterial hypertension (PAH).

More... »


CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

Copyright © 1995-2013 CenterWatch.